Hepatocellular Carcinoma Recurrence and Anesthesia

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02643173

Enrollment

259

Registered

2015-12-31

Start date

2015-09-30

Completion date

2019-06-30

Last updated

2019-11-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatocellular Carcinoma

Brief summary

The investigators will verify the prognosis of hepatocellular carcinoma (HCC) according to the main anesthetic agents used for the general anesthesia.

Interventions

OTHERVolatile anesthetics

OTHERIntravenous anesthetics

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

20 Years to 100 Years

Healthy volunteers

Inclusion criteria

* Patients undergoing surgery due to the HCC.

Exclusion criteria

* Patients undergoing re-operation due to the HCC. * Patients presenting distant metastasis. * Patients undergoing liver transplantation surgery.

Design outcomes

Primary

Measure	Time frame
Recurrence of HCC	Postoperative 2 year

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026